ArticleOncoimmunology
Intravenous delivery of the toll-like receptor 7 agonist SC1 confers tumor control by inducing a CD8+ T cell response.
Fulvia Vascotto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
17 papers cite it
cites it